NO306536B1 - Senkning av tromboksannivå ved perkutan tilförsel av aspirin - Google Patents

Senkning av tromboksannivå ved perkutan tilförsel av aspirin

Info

Publication number
NO306536B1
NO306536B1 NO933529A NO933529A NO306536B1 NO 306536 B1 NO306536 B1 NO 306536B1 NO 933529 A NO933529 A NO 933529A NO 933529 A NO933529 A NO 933529A NO 306536 B1 NO306536 B1 NO 306536B1
Authority
NO
Norway
Prior art keywords
aspirin
lowering
percutaneous administration
thromboxane levels
thromboxane
Prior art date
Application number
NO933529A
Other languages
English (en)
Norwegian (no)
Other versions
NO933529L (no
NO933529D0 (no
Inventor
Rudolph M Keimowitz
Desmond J Fitzgerald
Original Assignee
Gundersen Med Found
Univ Vanderbilt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gundersen Med Found, Univ Vanderbilt filed Critical Gundersen Med Found
Publication of NO933529D0 publication Critical patent/NO933529D0/no
Publication of NO933529L publication Critical patent/NO933529L/no
Publication of NO306536B1 publication Critical patent/NO306536B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Steroid Compounds (AREA)
NO933529A 1991-04-03 1993-10-01 Senkning av tromboksannivå ved perkutan tilförsel av aspirin NO306536B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68019591A 1991-04-03 1991-04-03
PCT/US1992/002576 WO1992020343A1 (fr) 1991-04-03 1992-04-02 Abaissement des taux de thromboxane par administration percutanee d'aspirine

Publications (3)

Publication Number Publication Date
NO933529D0 NO933529D0 (no) 1993-10-01
NO933529L NO933529L (no) 1993-11-29
NO306536B1 true NO306536B1 (no) 1999-11-22

Family

ID=24730117

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933529A NO306536B1 (no) 1991-04-03 1993-10-01 Senkning av tromboksannivå ved perkutan tilförsel av aspirin

Country Status (12)

Country Link
EP (1) EP0578780B1 (fr)
JP (1) JPH06510984A (fr)
KR (1) KR100247441B1 (fr)
AT (1) ATE244011T1 (fr)
AU (1) AU668352B2 (fr)
CA (1) CA2107587C (fr)
DE (1) DE69233116T2 (fr)
DK (1) DK0578780T3 (fr)
FI (1) FI934324A0 (fr)
NO (1) NO306536B1 (fr)
WO (1) WO1992020343A1 (fr)
ZA (1) ZA922464B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP921157A2 (en) * 1991-12-20 1994-10-31 Lohmann Therapie Syst Lts Transdermal system of applying acetilsalicilyc acid in antithrombosys therapy
WO1994013302A1 (fr) * 1991-12-20 1994-06-23 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Systeme d'administration transdermique contenant de l'acide acetylsalicylique pour la therapie antithrombotique et la prophylaxie contre le cancer
DE19616539A1 (de) * 1996-04-25 1997-11-06 Luitpold Pharma Gmbh Acetylsalicylsäure enthaltende alkoholische Lösungen zur perkutanen Anwendung, deren Verwendung zur antithrombotischen Therapie sowie Arzneimittel
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
JP2000351729A (ja) * 1999-06-08 2000-12-19 Shionogi & Co Ltd トロンボキサンa2受容体拮抗剤の経皮吸収製剤
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
WO2002085376A2 (fr) * 2001-04-19 2002-10-31 Universite De Montreal Procede permettant de reduire la production d'anions de superoxyde et traitement de stress oxydant
WO2011076401A1 (fr) 2009-12-23 2011-06-30 Holger Schankin Compositions pharmaceutiques sensiblement exemptes d'eau, contenant de l'acide acétylsalicylique

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2295753A1 (fr) * 1974-12-23 1976-07-23 Despin Jean Composition a base d'acide acetyl-salicylique a usage topique
FR2496459A1 (fr) * 1980-12-19 1982-06-25 Astier Laboratoires Docteur P Composition pharmaceutique sous forme d'un gel contenant de l'acide acetylsalicylique
IL68965A (en) * 1983-06-13 1987-02-27 Rafa Labor Ltd Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders
DE3583698D1 (de) * 1984-04-23 1991-09-12 Kao Corp Perkutaner absorptions-beschleuniger und diesen enthaltendes praeparat.
US4866046A (en) * 1988-05-31 1989-09-12 Top Laboratories, Inc. Low-dosage sublingual aspirin

Also Published As

Publication number Publication date
KR100247441B1 (ko) 2000-04-01
NO933529L (no) 1993-11-29
WO1992020343A1 (fr) 1992-11-26
DE69233116D1 (de) 2003-08-07
DK0578780T3 (da) 2003-08-18
JPH06510984A (ja) 1994-12-08
AU668352B2 (en) 1996-05-02
ATE244011T1 (de) 2003-07-15
NO933529D0 (no) 1993-10-01
CA2107587A1 (fr) 1992-10-04
DE69233116T2 (de) 2004-08-26
CA2107587C (fr) 2004-11-23
FI934324A0 (fi) 1993-10-01
EP0578780A1 (fr) 1994-01-19
AU2014292A (en) 1992-12-30
EP0578780B1 (fr) 2003-07-02
ZA922464B (en) 1992-12-30

Similar Documents

Publication Publication Date Title
KR930700103A (ko) (+)-α-(2,3-디메톡시페닐)-1-[2-(4-플루오로페닐)에틸]-4-피페리딘메탄올
DK0449247T3 (da) Farmaceutisk formulering indeholdende galanthamin til behandling af alkoholisme
HU895286D0 (en) Process for the preparation of steroid 5alfa-reductase inhibiting compounds and pharmaceutical compositions containing such compounds
AU3502289A (en) Method for administering the drug deprenyl so as to minimize the danger of side effects
SE8504967L (sv) Farmaceutisk komposition och forfarande for behandling av kroppen
IT8720698A0 (it) Composizione farmaceutica adattivita' terapeutica per il trattamento della demenza senile di tipo alzheimer.
ZA848369B (en) Pharmaceutical compositions containing bilobalid for the treatment of neuropathies
PT659427E (pt) Metodos de aumento da expressao de trombomodulina
NO306536B1 (no) Senkning av tromboksannivå ved perkutan tilförsel av aspirin
NO177663C (no) Fremgangsmåte til fremstilling av farmasöytisk preparat med nitroglyserin til perkutan administrering
FI944823A0 (fi) Galantamiinijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa
ES2181849T3 (es) Procedimiento para minimizar la perdida osea.
IL88971A (en) Disubstituted pyridines, process and intermediates, their preparation and pharmaceutical compositions containing them
ZA886097B (en) Pharmaceutical composition for the treatment of psoriasis
DE2961609D1 (en) Sila-substituted 1,4-dihydropyridine derivatives, processes for their preparation, pharmaceutical compositions and process for their preparation
EP0319962A3 (fr) Dérivés de la pipéridinyl méthanol pour le traitement de l'anxiété
NO952611D0 (no) Derivater av benzoylekgonin, ekgonin og ekgonidin som medisiner
HUT48119A (en) Process for producing pharmaceutical compositions against addiction to nicotine and comprising 2-pyrimidinyl-1-piperazine derivatives
IL111144A0 (en) Pharmaceutical compositions containing amiodarone for the treatment of heart failure
PT87634A (pt) Process for the preparation of pharmaceutical compositions containing n-imidazolyl derivatives of bicyclic compounds useful for the treatment of nephrophies
NO990283L (no) Formulering for behandling og/eller profylakse av demens
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
IL96161A0 (en) Application of n-methyl-2-(3-pyridyl)tetrahydrothiopyran-2-carbothioamide 1-oxide to the preparation of medicinal products intended for the treatment of coronary insufficiency
SE9303855D0 (sv) The use of ester of inositoltrisphosphate for the preparing of an analgetic medicamnet

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees